Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEI Pharma, Inc. - Common Stock (NQ:MEIP)

6.550 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MEI Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal 
Via Benzinga
MEI Pharma Announces Two Presentations at the American Association for Cancer Research Annual Meeting 2022
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From MEI Pharma, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
Analyzing Mei Pharma Inc's Short Interest
Mei Pharma Inc's (NASDAQ:MEIP) short percent of float has risen 10.86% since its last report. The company recently reported that it has 7.31 million shares sold short, which is 6.... 
Via Benzinga
64 Biggest Movers From Friday
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed... 
Via Benzinga
Expert Ratings For MEI Pharma
Analysts have provided the following ratings for MEI Pharma (NASDAQ:MEIP) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
Mid-Afternoon Market Update: Dow Falls 30 Points; Cutera Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Friday. The Dow traded down 0.09% to 34,677.25 while the NASDAQ fell... 
Via Benzinga
Analysts Cut Price Target On MEI Pharma As Stock Falls To 52-Week Low After Zandelisib Update
The FDA crushed MEI Pharma Inc's (NASDAQ: MEIP) hopes of winning accelerated approval for its PI3K inhibitor, zandelisib, on the strength of phase 2 data. In the... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
Mid-Day Market Update: Nasdaq Down 1%; Icosavax Shares Plummet
U.S. stocks pared gains midway through trading, with the Nasdaq Composite dropping 1% on Friday. The Dow traded up 0.02% to 34,715.99 while the NASDAQ fell 1.02% to 14,045.00... 
Via Benzinga
36 Stocks Moving In Friday's Mid-Day Session
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported... 
Via Benzinga
Futures Ramp To Session High As Oil Slides
S&P futures were near session highs, up 0.3% or 14 points to 4,526 around the time US traders got to their desks as investors evaluated economic risks from Federal Reserve monetary-policy tightening... 
Via Talk Markets
Penny Stocks Today: Why MEIP and HNST Are Plunging Friday
We're checking in on the latest penny stocks news for today with two companies that investors are watching fall on Friday! 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 25, 2022
Upgrades For Aris Water Solutions Inc (NYSE:ARIS), Capital One upgraded the previous rating of Equal-Weight to Overweight. The stock has a 52-week-high of $19.16 and a 52-week-low... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Tilray Brands (NASDAQ:TLRY) stock increased by 17.2% to $8.17 during Friday's pre-market session. The company's market cap stands at $3.9 billion. Sundial... 
Via Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
10 Biggest Price Target Changes For Friday
Jefferies cut the price target on MEI Pharma, Inc. (NASDAQ: MEIP) from $4 to $1. MEI Pharma shares fell 44.2% to $1.01 in pre-market trading. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, trader! Get ready for one more busy day of investing today with the biggest pre-market stock movers for Friday! 
Via InvestorPlace
34 Stocks Moving in Friday's Pre-Market Session
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
Why MEI Pharma Stock Is Plummeting After Hours
MEI Pharma Inc (NASDAQ: MEIP) shares are plunging in Thursday's after-hours session after the company provided an investor update following a recent meeting with the U.S... 
Via Benzinga
MEI Pharma and Kyowa Kirin Provide Regulatory Update on Zandelisib Following Meeting with the FDA
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q2, MEI Pharma's (NASDAQ:MEIP) reported sales totaled $18.22 million. Despite a 51.46% increase in earnings, the company posted a loss of $5.77 million. 
Via Benzinga
Recap: MEI Pharma Q2 Earnings
MEI Pharma (NASDAQ:MEIP) reported its Q2 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings MEI Pharma beat estimated... 
Via Benzinga
MEI Pharma Reports Second Quarter Fiscal Year 2022 Results and Operational Highlights
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments
From MEI Pharma, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
Upgrades BTIG upgraded the previous rating for Insulet Corp (NASDAQ:PODD) from Neutral to Buy. For the third quarter, Insulet had an EPS of $0.18, compared to year-ago... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.